We brought a bill to lower health care costs. You've heard a lot about that from Democrats, right? There was a bill on the House floor just a few weeks ago to lower health care costs by 11%, according to CBO.
Lower health care costs.
Occurrences
As our Congressman, Steve Scalise will work to give individuals and families more options to choose affordable healthcare and the ability to transfer that plan between jobs.
Evidence
Axios reported that Scalise said, "There are a number of things that are out there to give more tools to the departments," as House Republicans considered a health-fraud crackdown to produce savings.
AP reported that the Justice Department filed a lawsuit over a Medicaid home-care "sham bidding" scheme that allegedly let a contractor "siphon" millions from federal funds.
Congress.gov lists H.R.5378 as passed by the House on 2023-12-11, 320-71. CRS summarizes that the bill required providers and insurers to disclose information about health care costs, extended price-publication requirements, imposed PBM reporting and audit provisions, prohibited Medicaid PBM spread pricing, and required certain Medicare payment parity for drug administration services.
The House Clerk records Roll Call 724 on H.R.5378 as passed. The member table lists Scalise, Republican, Louisiana, voting Yea.
Congress.gov’s CRS summary says the enacted Inflation Reduction Act requires CMS to negotiate prices for certain Medicare prescription drugs beginning in 2026, requires rebates when certain Medicare drug prices rise faster than inflation, caps Medicare Part D out-of-pocket spending at $2,000 in 2025, limits Part D premium growth, eliminates cost-sharing for recommended adult vaccines, and caps Medicare insulin cost-sharing at $35 per month.
The House Clerk records Roll Call 420 on H.R.5376 as passed, 220-207. The member table lists Scalise, Republican, Louisiana, voting Nay.
Congress.gov records H.R.1 as becoming Public Law No. 119-21 on 2025-07-04. CRS summarizes health provisions including Medicaid eligibility redeterminations, work/community-engagement requirements, Medicaid cost-sharing up to $35 for some expansion adults, HSA eligibility expansions, restrictions on premium tax credit eligibility, changes to Medicare drug negotiation treatment of orphan drugs, and $10 billion per fiscal year for FY2026-FY2030 for rural health care support.
The House Clerk records Roll Call 190 on H.R.1 as passed, 218-214. The member table lists Scalise, Republican, Louisiana, voting Aye.
CBO estimated that H.R.1 provisions passed by the House would increase the number of people without health insurance by 10.9 million in 2034 relative to current-law baseline projections, including 7.8 million from Medicaid provisions, 1.3 million from marketplace provisions, and 2.3 million from health-insurance provisions, offset by interactions.
CBO wrote that H.R.1, as passed by the House, would increase the number of uninsured people by 10.9 million in 2034. It estimated Medicaid community-engagement requirements would reduce federal Medicaid coverage by about 5.2 million adults and increase the uninsured by 4.8 million; other provisions would increase uninsured counts through eligibility, marketplace, and premium tax credit restrictions.
Assessments
Scalise supported some cost-related health measures, including voting for the House-passed Lower Costs, More Transparency Act and the enacted 2025 reconciliation law. But the transparency bill did not become law, and the enacted reconciliation health provisions are mixed, with CBO projecting large coverage losses and some provisions adding cost-sharing or restricting eligibility. The clearest enacted federal drug-cost reductions came through the Inflation Reduction Act, which Scalise voted against, so they are not creditable to him. Overall, the record shows serious legislative effort but not delivery of the promised outcome of lower health care costs.
Scalise is shown pressing a health-fraud savings approach, but the evidence does not show that overall health care costs actually fell or that he directly caused a measurable reduction. The DOJ Medicaid-fraud action is related to protecting health-program dollars, not proof of the claimed outcome, so this merits at most partial credit.